St. Jude Medical Announces FDA Approval of High-Voltage Devices with New Safety Features St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of its next-generation Ellipse™ and SJM Assura™ portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators .
June 11, 2013 - Business Wire via Yahoo! Finance
St. Jude Expands Neuro Offerings St. Jude has entered into an exclusive distribution agreement with Spinal Modulation to sell its Axium Neurostimulator System in the global market.
June 10, 2013 - Zacks via Yahoo! Finance